257 results on '"Fenwick, Craig"'
Search Results
2. A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens
3. Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
4. 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.
5. Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19
6. Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
7. Antibodies to combat viral infections: development strategies and progress
8. Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
9. Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients
10. Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures
11. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
12. Measurement of circulating CD21−CD27− B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers
13. Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis
14. Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
15. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus
16. 360. A First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
17. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
18. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients
19. PERISCOPE: road towards effective control of pertussis
20. Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART
21. A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells
22. ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys
23. Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies
24. Persistent humoral immunity in children and adolescents throughout the COVID-19 pandemic (June 2020 to July 2022): a prospective school-based cohort study (Ciao Corona) in Switzerland
25. Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
26. Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
27. Ocrelizumab Impairs the Phenotype and Function of Memory CD8+T Cells
28. Persistence of Replication Competent HIV in Lymph Node Dendritic Cells Despite Years of Suppressive ART
29. CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses
30. The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection
31. Human Rhinovirus VPg Uridylylation AlphaScreen for High-Throughput Screening
32. P2G3 human monoclonal antibody neutralizes SARS-CoV-2 Omicron subvariants including BA.4 and BA.5 and Bebtelovimab escape mutants
33. Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells
34. Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
35. SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus
36. Omicron infection induces low-level, narrow-range SARS-CoV-2 neutralizing activity
37. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
38. Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
39. A high-throughput assay for HIV-1 integrase 3′-processing activity using time-resolved fluorescence
40. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus
41. SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties
42. Heterogenous Cellular and Humoral Immune Trajectories after SARS-CoV-2 Infection: Compensatory Responses in a Population-Based Cohort
43. Increased CD21-CD27- atypical memory B cells as a biomarker of clinical disease activity in patients with systemic lupus erythematosus
44. A highly potent antibody effective against SARS-CoV-2 variants of concern
45. Reactivation of IgA vasculitis after COVID-19 vaccination
46. A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma
47. Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor–Related Cholangiohepatitis
48. SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study
49. Defining the mechanism of action in a novel class of anti-PD-1 antibodies
50. A highly potent antibody effective against SARS-CoV-2 variants of concern
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.